# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 12, "Diabet Med .", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasJournal> \"Diabet Med .\"."
1, PublicationYear, 13, 17, "2012", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasPublicationYear> \"2012\"."
18, Title, 102, 321, "A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti - hyperglycaemic medication : results of the PARADIGM study .", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasTitle> \"A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti - hyperglycaemic medication : results of the PARADIGM study .\"."
62981, Lispro75/25, 120, 141, "insulin lispro mix 25", "", 
12, InsulinGlargine, 147, 155, "glargine", "", 
3, Lispro, 161, 167, "lispro", "", 
17, Precondition, 179, 287, "patients with Type 2 diabetes who have inadequate glycaemic control on oral anti - hyperglycaemic medication", "", "<http://ctro/data#Population_35792> <http://ctro/data#hasPrecondition> \"patients with Type 2 diabetes who have inadequate glycaemic control on oral anti - hyperglycaemic medication\"."
13, Type2Diabetes, 193, 208, "Type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
62994, OralAntidiabeticAgent, 250, 287, "oral anti - hyperglycaemic medication", "", 
19, Author, 322, 332, "Bowering K", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Bowering K\"."
20, Author, 341, 348, "Reed VA", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Reed VA\"."
21, Author, 351, 361, "Felicio JS", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Felicio JS\"."
22, Author, 364, 372, "Landry J", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Landry J\"."
23, Author, 375, 379, "Ji L", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Ji L\"."
24, Author, 382, 392, "Oliveira J", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasAuthor> \"Oliveira J\"."
25, Canada, 535, 541, "Canada", "", "<http://ctro/data#Population_35792> <http://ctro/data#hasCountry> <http://ctro/data#Canada>."
29, ObjectiveDescription, 650, 878, "To test the hypothesis that initiation and intensification with 25 % insulin lispro , 75 % insulin lispro protamine suspension ( LM25 ) , is non - inferior to initiation and intensification with glargine + insulin lispro therapy", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasObjectiveDescription> \"To test the hypothesis that initiation and intensification with 25 % insulin lispro , 75 % insulin lispro protamine suspension ( LM25 ) , is non - inferior to initiation and intensification with glargine + insulin lispro therapy\"."
62982, Lispro75/25, 714, 765, "25 % insulin lispro , 75 % insulin lispro protamine", "", 
62983, Lispro75/25, 779, 783, "LM25", "", 
26, InsulinGlargine, 845, 853, "glargine", "", 
27, Lispro, 856, 870, "insulin lispro", "", 
30, ObjectiveDescription, 879, 918, "on change from baseline in HbA ( 1c ) .", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasObjectiveDescription> \"on change from baseline in HbA ( 1c ) .\"."
95, TimePoint, 894, 902, "baseline", "", 
28, HbA1c, 906, 916, "HbA ( 1c )", "", 
31, Randomized, 937, 947, "randomized", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
32, CTDesign, 950, 967, "non - inferiority", "", "<http://ctro/data#CTDesign_35875> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_35875>."
33, Parallel, 992, 1000, "parallel", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
34, CTDesign, 1003, 1014, "prospective", "", "<http://ctro/data#CTDesign_35877> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_35877>."
75, Multicenter, 1017, 1032, "multi - country", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
36, Duration, 1035, 1044, "48 - week", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTduration> \"48 - week\"."
35, OpenLabel, 1047, 1059, "open - label", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
37, NumberPatientsCT, 1083, 1086, "426", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasNumberPatientsCT> \"426\"."
15, Type2Diabetes, 1094, 1109, "Type 2 diabetes", "", 
108, Precondition, 1094, 1177, "Type 2 diabetes inadequately controlled with oral anti - hyperglycaemic medications", "", 
62995, OralAntidiabeticAgent, 1139, 1177, "oral anti - hyperglycaemic medications", "", 
110, Frequency, 1226, 1235, "one daily", "", "<http://ctro/data#Intervention_35818> <http://ctro/data#hasFrequency> \"one daily\"."
62984, Lispro75/25, 1236, 1240, "LM25", "", "<http://ctro/data#Medication_35836> <http://ctro/data#hasDrug> <http://ctro/data#Lispro75/25>."
62987, IntramuscularInjection, 1241, 1250, "injection", "", "<http://ctro/data#Medication_35836> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#IntramuscularInjection>."
111, Frequency, 1271, 1282, "three daily", "", 
62986, IntramuscularInjection, 1283, 1293, "injections", "", 
44, NumberPatientsArm, 1318, 1321, "211", "", "<http://ctro/data#Arm_35800> <http://ctro/data#hasNumberPatientsArm> \"211\"."
62988, PerProtocol, 1324, 1336, "per protocol", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#PerProtocol>."
46, FinalNumPatientsArm, 1345, 1348, "177", "", "<http://ctro/data#Arm_35800> <http://ctro/data#hasFinalNumPatientsArm> \"177\"."
42, Frequency, 1378, 1387, "one daily", "", "<http://ctro/data#Intervention_35824> <http://ctro/data#hasFrequency> \"one daily\"."
41, InsulinGlargine, 1388, 1396, "glargine", "", "<http://ctro/data#Medication_35843> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
62989, IntramuscularInjection, 1397, 1406, "injection", "", "<http://ctro/data#Medication_35843> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#IntramuscularInjection>."
114, Frequency, 1429, 1440, "three daily", "", "<http://ctro/data#Intervention_35830> <http://ctro/data#hasFrequency> \"three daily\"."
7, Lispro, 1441, 1455, "insulin lispro", "", 
62990, IntramuscularInjection, 1456, 1466, "injections", "", "<http://ctro/data#Medication_35850> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#IntramuscularInjection>."
45, NumberPatientsArm, 1491, 1494, "212", "", "<http://ctro/data#Arm_35809> <http://ctro/data#hasNumberPatientsArm> \"212\"."
62991, PerProtocol, 1497, 1509, "per protocol", "", 
47, FinalNumPatientsArm, 1518, 1521, "184", "", "<http://ctro/data#Arm_35809> <http://ctro/data#hasFinalNumPatientsArm> \"184\"."
62992, Lispro75/25, 1536, 1540, "LM25", "", 
48, InsulinGlargine, 1583, 1591, "glargine", "", 
49, Lispro, 1594, 1608, "insulin lispro", "", 
50, ConfIntervalResValue, 1632, 1662, "upper limit of 95 % CI < 0 . 4", "", 
127, LeastSquaresMean, 1674, 1694, "least - squares mean", "", "<http://ctro/data#Endpoint_35887> <http://ctro/data#hasAggregationMethod> <http://ctro/data#LeastSquaresMean>."
51, ConfIntervalResValue, 1708, 1715, "95 % CI", "", 
52, HbA1c, 1721, 1731, "HbA ( 1c )", "", "<http://ctro/data#Endpoint_35887> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
62996, Lispro75/25, 1734, 1738, "LM25", "", 
54, InsulinGlargine, 1745, 1753, "glargine", "", 
9, Lispro, 1756, 1770, "insulin lispro", "", 
57, DiffGroupAbsValue, 1776, 1783, "- 0 . 4", "", "<http://ctro/data#DiffBetweenGroups_35946> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 4\"."
79775, Millimoles_per_mole, 1784, 1794, "mmol / mol", "", "<http://ctro/data#Endpoint_35887> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_mole>."
55, ConfIntervalDiff, 1797, 1821, "95 % CI - 2 . 7 to 1 . 9", "", "<http://ctro/data#DiffBetweenGroups_35946> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 2 . 7 to 1 . 9\"."
58, DiffGroupAbsValue, 1826, 1834, "- 0 . 04", "", 
60, Percentage, 1835, 1836, "%", "", 
56, ConfIntervalDiff, 1839, 1865, "95 % CI - 0 . 25 to 0 . 17", "", 
136, HbA1c, 1987, 1997, "HbA ( 1c )", "", 
76, PostprandialBloodGlucose, 2009, 2035, "postprandial blood glucose", "", 
77, InsulinDose, 2061, 2073, "insulin dose", "", 
63, EndPointDescription, 2076, 2096, "number of injections", "", 
137, BodyWeight, 2101, 2107, "weight", "", 
65, ObservedResult, 2108, 2175, "change during the course of the study were similar in both groups .", "", 
68, ObservedResult, 2176, 2219, "Patients in both groups experienced similar", "", 
66, Hypoglycemia, 2220, 2233, "hypoglycaemia", "", 
68, ObservedResult, 2234, 2239, "rates", "", 
67, EndPointDescription, 2244, 2258, "safety profile", "", 
72, ConclusionComment, 2275, 2496, "For patients with Type 2 diabetes inadequately controlled with oral anti - hyperglycaemic medications , glycaemic control when initiating and intensifying with LM25 therapy was found to be non - inferior to treatment with", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasConclusionComment> \"For patients with Type 2 diabetes inadequately controlled with oral anti - hyperglycaemic medications , glycaemic control when initiating and intensifying with LM25 therapy was found to be non - inferior to treatment with\"."
14, Type2Diabetes, 2293, 2308, "Type 2 diabetes", "", 
69, OralAntidiabeticAgent, 2338, 2376, "oral anti - hyperglycaemic medications", "", 
62993, Lispro75/25, 2435, 2439, "LM25", "", 
71, InsulinGlargine, 2497, 2505, "glargine", "", 
73, ConclusionComment, 2497, 2532, "glargine + insulin lispro therapy .", "", "<http://ctro/data#ClinicalTrial_35776> <http://ctro/data#hasConclusionComment> \"glargine + insulin lispro therapy .\"."
11, Lispro, 2508, 2522, "insulin lispro", "", 
74, PMID, 2663, 2671, "22672081", "", "<http://ctro/data#Publication_35769> <http://ctro/data#hasPMID> \"22672081\"."
